DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Royal RE, Levy C, Turner K. et al.
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.
J Immunother 2010;
33 (08) 828-833
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.